FASLG and hepatocellular carcinoma: Moreover, some studies have revealed that HCC cells show resistance to apoptosis because of their suppression of FAS expression [38], and serum levels of soluble FASL in patients with hepatocellular carcinoma show potential as a clinical parameter to evaluate prognosis [39].